Stock EDIT EDITAS MEDICINE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Editas Medicine, Inc.

Equities

EDIT

US28106W1036

Real-time Estimate Cboe BZX
Other stock markets
 12:34:46 2024-06-03 pm EDT 		5-day change 1st Jan Change
5.385 USD +3.56% Intraday chart for Editas Medicine, Inc. +1.31% -46.79%
May. 30 Evercore ISI Cuts Price Target on Editas Medicine to $7 From $15, Maintains In Line Rating MT
May. 14 Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June
GL
Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June
AQ
Editas Medicine Preclinical Data Highlights Advancement Of In Vivo Gene Editing Medicine Technologies at The American Society Of Gene And Cell Therapy Annual Meeting
AQ
Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting
GL
Editas: Q1 Earnings Snapshot
AQ
Editas Medicine Announces First Quarter 2024 Results and Business Updates
GL
Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events
GL
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
GL
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
GL
Editas Medicine : April 2024 Corporate Presentation
PU
Editas Medicine : Corporate Effectiveness Report April 2024
PU
Editas: Q4 Earnings Snapshot
AQ
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
GL
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
AQ
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events
GL
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events
AQ
Editas Medicine to Participate in Upcoming Investor Conferences
GL
Editas Medicine to Participate in Upcoming Investor Conferences
AQ
Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference
GL
Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EDIT Stock
  4. News Editas Medicine, Inc.
  5. Press Releases